Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pediatric Radiology

• Publication date

  2018-04-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00247-017-3999-2PMID 29623352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.

  2017cited by this paper
• Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.

  2017cited by this paper
• Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams

  2016cited by this paper
• Macrocyclic and Other Non–Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function

  2016cited by this paper
• Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent

  2016cited by this paper
• Gadolinium-Induced Fibrosis.

  2016cited by this paper
• Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience.

  2016cited by this paper
• Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.

  2016cited by this paper
• MRI Brain Signal Intensity Changes of a Child During the Course of 35 Gadolinium Contrast Examinations

  2015cited by this paper
• Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

  2015cited by this paper
• Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.

  2015cited by this paper
• Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study

  2015cited by this paper
• Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy.

  2015cited by this paper
• Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration

  2015cited by this paper
• High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

  2015cited by this paper
• Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.

  2007cited by this paper
• Added Utility of Gadolinium in the Magnetic Resonance Imaging (MRI) Workup of Seizures in Children Younger Than 2 Years

  2007cited by this paper
• Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.

  2007cited by this paper
• Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass Spectroscopy

  2006cited by this paper
• Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

  2006cited by this paper
• Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

  2006cited by this paper
• Value of gadolinium in brain MRI examinations for developmental delay.

  2006cited by this paper
• Comparison of plain and Gd-DTPA-enhanced MR-imaging in children

  2005cited by this paper
• Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.

  1994cited by this paper
• Gd-DTPA-enhanced cranial MR imaging in children: initial clinical experience and recommendations for its use.

  1989cited by this paper

• Contrast-Enhanced Brain MRI for Ambulatory Evaluation of Headache: Comprehensive or Excessive?

  2025cites this paper
• Diagnostic accuracy of MRI without gadolinium for follow-up of pilocytic astrocytoma in the paediatric population.

  2025cites this paper
• MRT bei kindlichen Kopfschmerzen

  2024cites this paper
• Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?

  2024cites this paper
• Recent progress of emitting long-wavelength carbon dots and their merits for visualization tracking, target delivery and theranostics

  2023cites this paper
• Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis

  2022cites this paper
• Acute care diagnostics in children for general radiologists – not alone in the hospital at night

  2022cites this paper
• Imagerie des infections cérébroméningées du nouveau-né et de l’enfant

  2022cites this paper
• MRI Protocol for Pituitary Assessment in Children with Growth or Puberty Disorders—Is Gadolinium Contrast Administration Actually Needed?

  2021cites this paper
• Contrast-free MRI Protocol for Pituitary Assessment in Children with Growth or Puberty Disorders: A Practical Approach.

  2021cites this paper
• Lymphom-Diagnostik bei Kindern auch ohne Kontrastmittel aussagekräftig

  2020cites this paper
• Construction of Pepstatin A-Conjugated ultrasmall SPIONs for targeted positive MR imaging of epilepsy-overexpressed P-glycoprotein.

  2019cites this paper
• Detection of recurrent brain tumors in children: No significant difference in sensitivity between unenhanced and contrast-enhanced MRI

  2019cites this paper
• Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging

  2019cites this paper
• Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?

  2018cites this paper